| Followers | 113 |
| Posts | 19900 |
| Boards Moderated | 1 |
| Alias Born | 03/28/2007 |
Saturday, September 19, 2009 12:29:25 PM
In the last quarter there's been some humongous pharma/biotech runners associated with markets that have hundreds of millions of dollars in potential revenue, I can't wait until we get FDA approval for our prescription drug that has a multi BILLION dollar revenue market. Absolute no brainer IMO, GLTY.
Recent NPHC News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 03/25/2026 06:38:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 03/11/2026 07:22:37 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/17/2026 07:11:39 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/02/2026 06:52:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/23/2025 06:15:54 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/17/2025 10:08:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 11/24/2025 06:48:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/28/2025 08:02:10 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/23/2025 05:43:20 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/16/2025 08:38:46 PM

